Ampoules are a traditional type of primary packaging for pharmaceutical drugs that offer a good choice for emerging markets. Here, Lothar Haaf and Dr Volker Rekowski discuss the benefits of this product.
Packaging technology has undoubtedly progressed, but, it is unclear as to whether this is paralleled in creating a suitable level of child resistance. Here, Richard Quelch discusses some of the key aspects of making medicine packaging child resistant
Facts and figures published by the manufacturers’ organisation, EEF, and Santander show that British manufacturing has climbed up the global rankings to now be the eighth largest industrial nation.
Data published by the BioIndustry Association (BIA) has revealed that most healthcare professionals are not aware of government-led initiatives, such as the Accelerated Access Review, aimed at improving innovation adoption across the NHS.
As temperature-control requirements to maintain a pharma compound’s stability are constantly evolving, innovation in packaging is increasingly playing a vital role in global cold chain logistics. Paul Terry, Peli BioThermal, tells us more
This diary entry from R&D software provider, IDBS, looks at how individuals, laboratories and external collaborators can make their work more accurate with the help of cloud-based software.
Neil Pullman, principal architect at, Boulting Environmental Services, explores the differences between BIM Levels, their benefits and what it means for the pharmaceutical sector.
As pressure to get drugs to the human clinical trial stage increases more companies are looking to outsource not only non-core functions but major areas of R&D. Here, Praveen C. Surana, ELC Group, examines outsourcing projects in more detail.
Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space?
The latest report from business information and analytics provider, GlobalData, has indicated that immune-oncology (IO) will become the fifth pillar of cancer treatment, joining surgery, radiotherapy, chemotherapy and other targeted treatments.
